[{"Assets_0_Q2_USD":63210000000.0,"CommonStockSharesOutstanding_0_Q2_shares":1267000000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":3665000000.0,"NetIncomeLoss_1_Q2_USD":1880000000.0,"NetIncomeLoss_2_Q2_USD":3855000000.0,"StockholdersEquity_0_Q2_USD":22616000000.0,"EarningsPerShareBasic_1_Q2_USD":1.48,"EarningsPerShareBasic_2_Q2_USD":3.03,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":1270000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":1273000000.0,"Ticker":"GILD","CIK":"882095","name":"GILEAD SCIENCES INC","OfficialName":"Gilead Sciences Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"78838305412.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190806"}]